For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Minimal Intensity Intervention | Patients assigned to this group will received the Minimal intensity intervention. Minimal intensity intervention: The minimal intensity intervention control includes the Group Lifestyle Balance (GLB) videos (DVD or online), standardized messages, and access to a lifestyle coach if initiated by the participant. | 0 | None | 15 | 212 | 48 | 212 | View |
| HOMBRE | Patients assigned to this group will receive the HOMBRE intervention HOMBRE: HOMBRE is a Group Lifestyle Balance (GLB)-based intervention tailored for men and available in 3 delivery modalities (coach-facilitated individual approach, coach-led online virtual groups, and coach-led in-person groups). A lifestyle coach will support men in making an informed choice of modality and will provide ongoing individualized feedback. All delivery modalities provide the same evidence-based curriculum and include self-monitoring and individualized feedback from the lifestyle coach. | 0 | None | 14 | 212 | 52 | 212 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Endocrine disorders | SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |
| Gastrointestinal Disorders | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Immune System Disorders | SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| Musculoskeletal and Connective Tissue Disorders | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Renal and Urinary Disorders | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Respiratory, Thoracic and Mediastinal Disorders | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Skin and Subcutaneous Tissue Disorders | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Cardiac disorders | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Infections and Infestations | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Musculoskeletal and Connective Tissue Disorders | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Skin and Subcutaneous Tissue Disorders | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Endocrine Disorders | SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |
| Gastrointestinal Disorders | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| General disorders | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Nervous System Disorders | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Renal and Urinary Disorder | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Respiratory, Thoracic and Mediastinal Disorders | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Cardiac disorders | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |